Document is current
Any future updates will be listed below
-
Authors
Demel, Ivo https://orcid.org/0000-0002-0518-9581
Skopal, David
Šafránková, Eliška
Rozsívalová, Petra
Jindra, Pavel
Šrámek, Jiří
Turková, Adéla
Vydra, Jan
Labská, Klára
Vedrová, Jana
Čerňan, Martin
Szotkowski, Tomáš
Móciková, Heidi
Hynková, Lenka
Šušol, Ondrej
Kováčová, Ingrid
Belada, David
Hájek, Roman
-
Funding
Funding for this research was provided by:
Ministerstvo Zdravotnictví Ceské Republiky (00669806, UHHK, 00179906)
Univerzita Palackého v Olomouci (IGA_LF_2023_005)
lékařská fakulta Univerzity Karlovy (programme Cooperatio, research area ONCO, SVV 260 665)
University Hospital in Ostrava
- License Information
-
More Information
Article History
Received: 17 September 2023
Accepted: 28 November 2023
First Online: 14 December 2023
Declarations
:
: Ivo Demel—AstraZeneca (advisory board member); David Belada—AstraZeneca (advisory board member); Martin Čerňan—AstraZeneca (advisory board member); Pavel Jindra—AstraZeneca (advisory board member). Other authors have no competing interests to declare.
